FINWIRES · TerminalLIVE
FINWIRES

Centerra Gold Posts Higher Revenue, Adjusted Profit for Fist Quarter; Issues 2026 Production Outlook

作者

-- Centerra Gold (CG.TO, CGAU) after trade Wednesday reported higher revenue and adjusted profit for the first quarter.

The company said its adjusted profit, excluding most one-time items, rose to US$88.2 million, or US$0.44 per share, in the period, up from US$26.4 million, or US$0.13 per share, a year ago. FactSet expected US$0.43 per share.

Revenue rose 62% to US$484.7 million from US$299.5 million a year prior. FactSet projected US$373.5 million.

Total gold production was 68,001 ounces and copper production was 14.2-million pounds. Gold sales for the quarter were 72,935 ounces at an average price of US$4,172 per ounce, while copper sales were 14.9-million pounds at US$4.48 per pound. These prices include the impact of the Mount Milligan streaming agreement with Royal Gold, the company said.

"Our financial position strengthened this quarter, with our cash balance increasing to $543 million. This was achieved while we continued to invest in our internal growth pipeline, built working capital at Langeloth, and returned $33 million to shareholders through share buybacks and dividends in the quarter," Chief Executive Paul Tomory said.

For 2026, the company expects total gold production of 250,000 to 280,000 ounces and total copper production is projected at 50-million to 60-million pounds.

Centerra shares closed down C$0.75 to C$23.90 on the Toronto Stock Exchange.

相关文章

Asia

截至3月31日,光电系统公司报告合同积压量增长

根据周四提交给澳大利亚证券交易所的文件显示,截至3月31日,Electro Optic Systems Holdings(ASX:EOS)的合同积压额为5.18亿澳元,较2025年底增长13%。 文件还显示,该公司截至3月底的非限制性现金持有量为9510万澳元,较2025年底减少1180万澳元。

$ASX:EOS
Asia

Regis Healthcare预计2026财年基础EBITDA将达到预期上限

Regis Healthcare(ASX:REG)周四向澳大利亚证券交易所提交的文件显示,该公司预计2026财年息税折旧摊销前利润(EBITDA)约为1.35亿澳元,处于此前预期的上限。 文件显示,该公司旗下成熟养老院第三财季的平均入住率约为96%。 该公司表示,第三财季净可退还住宿押金(RAD)现金流入为4450万澳元,使今年迄今为止的净RAD现金流入总额达到2.23亿澳元。 该公司补充道,随着住户的更替,将已支付的RAD逐步重新定价至当前公布的房间价格,预计将随着时间的推移产生约4亿澳元的净经营现金流入,同时还将增加RAD留存收益。

$ASX:REG
Research

研究快讯:CFRA维持对亿滋国际股票的“持有”评级

独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将MDLZ的12个月目标价上调1美元至63美元,相当于2027年预期每股收益的19倍,与MDLZ的历史平均预期市盈率一致。我们将2026年每股收益预期上调0.06美元至3.08美元,但将2027年预期下调0.11美元至3.32美元。我们仍然认为巧克力和饼干业务面临一些不利因素,尽管有利的汇率在一定程度上有所帮助。MDLZ强调了通过加大促销活动刺激增长的计划,这可能会提振收入(我们预计2027年收入将加速增长),但同时也可能导致利润率下降。我们注意到,节约成本的措施也有助于缓解部分利润率压力。 MDLZ已对2026年的可可投入成本进行了大部分套期保值,但对2027年的套期保值较少。因此,如果2025年可可价格大幅上涨的趋势没有重现,成本压力有望在2027年缓解,从而提升公司盈利。股票回购也对每股收益有所贡献,值得注意的是,2026年第一季度的股票数量较上年同期减少了1.5%。

$MDLZ